Baxter International Inc(us:BAX)
34.23
+1.42%
Updated on 2025-03-31
Open:33.65
Close:34.23
High:34.51
Low:33.63
Prev Close:33.75
Volume:3.60M
Turnover:122.84M
Turnover Ratio:0.70%
Shares:512.92M
MarketCap:17.56B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 982 | 454021659 | 89.01% | 92 | 268 | 453 |
| 2024-03-31 | 971 | 448236133 | 87.96% | 109 | 298 | 390 |
| 2023-12-31 | 988 | 457842789 | 90.19% | 119 | 254 | 481 |
| 2023-09-30 | 1009 | 438958157 | 86.53% | 77 | 279 | 498 |
| 2023-06-30 | 1021 | 431497491 | 85.21% | 108 | 288 | 454 |
| 2023-03-31 | 1037 | 429279015 | 84.87% | 88 | 323 | 470 |
| 2022-12-31 | 1078 | 436726142 | 86.58% | 107 | 310 | 476 |
| 2022-09-30 | 1102 | 427752647 | 84.86% | 71 | 328 | 500 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 63034735 | 12.36% | 2069883 | 3.40% |
| 2024-06-30 | Vanguard Group Inc | 59960049 | 11.76% | 212489 | 0.36% |
| 2024-06-30 | Pzena Investment Management Llc | 30823004 | 6.04% | 6417584 | 26.30% |
| 2024-06-30 | Dodge & Cox | 27522745 | 5.40% | 20850 | 0.08% |
| 2024-06-30 | State Street Corp | 21408207 | 4.20% | 66703 | 0.31% |
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 14796015 | 2.90% | -1879900 | -11.27% |
| 2024-06-30 | Geode Capital Management, Llc | 11985884 | 2.35% | 529974 | 4.63% |
| 2024-06-30 | Harris Associates L P | 10328934 | 2.02% | 356650 | 3.58% |
| 2024-06-30 | Ameriprise Financial Inc | 9367847 | 1.84% | -5850575 | -38.44% |
| 2024-06-30 | Invesco Ltd. | 7905745 | 1.55% | 1268463 | 19.11% |
About
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Address:One Baxter Parkway
Website:http://www.baxter.com
Market Movers